Comprehensive Study Guide: Women's Health, Gynecologic Cancers, Breast Disorders, and Obstetric Emergencies

Intimate Partner Violence and Abuse

• Definition and Scope of Intimate Partner Violence (IPV):

  • IPV includes threatened or actual physical violence, sexual violence, or psychological/emotional abuse committed by a current or former partner.
  • Abuse often begins as subtle emotional control and slowly escalates into physical or severe psychological aggression.
  • IPV occurs across all demographic groups, socioeconomic classes, cultural backgrounds, and relationship types.

• Generation-to-Generation Continuation of Violence:

  • Violence is a learned behavior that is reinforced through exposure.
  • Without targeted intervention, the cycle of violence continues uninterrupted across generations.
  • Children who witness IPV are at profound risk for long-term behavioral, emotional, and academic difficulties.

• The Cycle of Violence:

  • Tension Building Phase: Characterized by rising friction, emotional abuse, minor verbal arguments, and growing fear.
  • Physically Abusive Phase: The acute battering incident involving severe physical, sexual, or verbal aggression.
  • Reconciliation Phase: Also known as the honeymoon phase; the abuser expresses remorse, promises change, and offers gifts or affection.
  • Period of Calm: A temporary peaceful phase where abuse recedes until tension begins building again.

• IPV Across the Lifespan and Vulnerable Populations:

  • Pregnancy significantly increases the risk of IPV onset or escalation.
  • The presence of children does not protect a victim from experiencing ongoing abuse.
  • Older adults are also at high risk for abuse and neglect.
  • Abusers are almost universally individuals known to the victim rather than strangers.
  • Nurses play a critical, front-line role in early identification, intervention, and safety planning.

• Clinical Red Flags and Observational Indicators:

  • Partner Behaviors: The partner insists on answering questions for the patient, refuses to leave the room, or exhibits overly controlling conduct.
  • Gynecologic & Exam Responses: Extreme difficulty or distress during pelvic examinations, along with unexplained nonadherence to medical recommendations.
  • Somatic & Psychological Symptoms: Vague, generalized somatic complaints, persistent anxiety, depression, or post-traumatic stress disorder (PTSD) symptoms.
  • Care Utilization Patterns: Missed or late prenatal care appointments and frequent, unscheduled emergency or urgent care visits.

• Nursing Interventions and Care Protocol:

  • Universal Screening: Screen all patients routinely using direct or indirect standardized screening questions.
  • Privacy Maintenance: Ensure absolute privacy by physically separating the patient from their partner before conducting screening or discussing abuse.
  • Safety Assessment: Systematically assess immediate safety for both the patient and any dependent children.
  • Supportive Communication: Explicitly communicate belief, empathy, nonjudgment, and validation of the patient's feelings.
  • Objective Documentation: Document injuries and patient statements objectively and verbatim; adhere strictly to mandatory reporting statutes where required.
  • Referral & Safety Planning: Assist with safety planning (Teaching Guidelines 9.1) and provide direct referrals to emergency shelters and national/local crisis hotlines.

• Trauma-Informed Care (TIC) Practices:

  • Always request explicit permission before physically touching the patient.
  • Explain every step of an examination in advance and empower the patient by stating they can pause or stop the procedure at any time.
  • Keep the patient fully clothed until examination is necessary, ensuring proper draping and privacy throughout.
  • Proceed entirely at the patient's pace while offering choices whenever possible.

Obstetric Emergency: Shoulder Dystocia

• Definition and Epidemiology:
  • Definition: An obstetric emergency occurring when the fetal head delivers, but the fetal shoulders (typically the anterior shoulder) fail to deliver because the anterior shoulder becomes wedged behind the maternal pubic bone.
  • Incidence: Occurs in $0.6\%$ to $1.4\%$ of all vaginal deliveries.
  • Recurrence Risk: Subsequent pregnancies carry a recurrence risk of $16\%$
  • Critical Time Threshold: Fetal mortality reaches $50\%$ if delivery is delayed beyond $5\text{ minutes}$ from head delivery.

• Risk Factors:

  • Prior history of shoulder dystocia.
  • Maternal diabetes (gestational or pre-gestational).
  • Fetal macrosomia (fetal birthweight exceeding $4000\,\text{g}$).
  • Maternal obesity.
  • Postterm gestation ($42+$ weeks).
  • History of delivering a previous macrosomic infant.

• Emergency Management Protocol — The HELPERR Mnemonic:

  • H: Call for Help (immediately notify obstetrical provider, anesthesia, neonatal resuscitation team, and extra nursing support).
  • E: Evaluate for Episiotomy (considered to increase internal space for operator hand placement).
  • L: Legs to chest for McRoberts maneuver.
  • P: Pressure on pubic bone / Suprapubic pressure.
  • E: Enter for internal rotational maneuvers.
  • R: Remove posterior arm.
  • R: Roll the patient onto hands and knees (Gaskins maneuver) and re-attempt maneuvers.

• Specific Physical Maneuvers:

  • McRoberts Maneuver: Hyperflexion and abduction of the maternal legs against the abdomen, which flattens the sacral curve and rotates the symphysis pubis cephalad.
  • Suprapubic Pressure: An assistant applies downward and lateral pressure directly above the pubic bone to dislodge the impacted anterior shoulder.
  • Rubin's Maneuver: The operator inserts a hand vaginally behind the anterior shoulder and rotates it toward the fetal midline (towards the infant's nose) combined with suprapubic pressure.
  • Modified Woods Screw Maneuver: The operator inserts a hand behind the posterior shoulder and rotates it $180^\circ$ toward the midline to release the impacted anterior shoulder.
  • Delivery of Posterior Shoulder: The operator reaches along the posterior arm, flexes the arm at the elbow, sweeps it across the fetal chest, and delivers the posterior arm and hand.
  • Efficacy: Approximately $40\%$ to $50\%$ of shoulder dystocias are resolved using a combination of McRoberts maneuver and suprapubic pressure alone.

• Advanced Maneuvers for Refractory Cases:

  • Intentional Fracture of the Clavicle: Place two fingers underneath the fetal clavicle and pull outward away from the fetal chest (never push inward toward internal structures) to reduce shoulder circumference.
  • Gaskins Maneuver: Rolling the patient onto all-fours (hands and knees) to alter pelvic dimensions.
  • Symphysiotomy: A Foley catheter is placed, local anesthetic is injected, and the upper-to-middle third of the interpubic ligament is incised; the operator rotates $180^\circ$ and incises the remaining upper third while pushing superiorly.
  • Zavanelli Maneuver: Cephalic replacement where the fetal head is rotated back to an occiput anterior/posterior position, flexed, and pushed back into the uterine cavity, followed immediately by emergent cesarean section.

• Post-Delivery Actions & Documentation:

  • Umbilical Cord Gases: Immediately obtain arterial and venous cord blood gases post-delivery.
  • Parental Debriefing: Conduct a detailed debriefing session with the parents to explain the emergency, interventions used, and recurrence risk ($16\%$).
  • Documentation: Extensively document all timeline details, sequence of maneuvers, clinical personnel present, and neonatal outcomes.

Benign and Malignant Disorders of the Breast

• Benign Breast Disorders:

  • Noncancerous lesions account for approximately $90\%$ of all identified breast lumps and are most common from puberty through menopause.
  • Fibrocystic Changes & Cysts: The most common benign disorder, presenting with cyclic breast pain, tenderness, and lumpy/nodular breast tissue that worsens during the premenstrual phase (Teaching Guidelines 6.1).
  • Fibroadenomas: Typically painless, firm, smooth, rubbery, well-delineated, and highly mobile breast masses. They are hormone-sensitive, increasing in size during pregnancy and regressing after menopause.

• Malignant Breast Disorders (Breast Cancer):

  • Origin & Histology: Most breast carcinomas originate within the milk ducts, making Invasive Ductal Carcinoma (IDC) the most common type; IDC carries a risk of regional and distant metastasis.
  • Hallmark Physical Finding: A painless, firm, fixed (non-mobile) breast mass with irregular borders.
  • Benign vs. Malignant Comparison (Table 6.3):
  • Benign Mass: Smooth, mobile, soft-to-rubbery consistency, often tender, cyclic changes.
  • Malignant Mass: Fixed to underlying tissue/skin, firm or hard, non-tender, non-cyclic, associated with skin dimpling, nipple retraction, or spontaneous bloody discharge.

• Breast Cancer Screening & Diagnostic Testing:

  • Primary Screening: Mammography combined with general breast self-awareness.
  • Diagnostic Pathway: Breast imaging (diagnostic mammomorphology and ultrasound) followed by definitive tissue biopsy.

• Breast Cancer Treatment Modalities:

  • Surgical Options: Lumpectomy (breast-conserving surgery), Mastectomy (partial, total, or modified radical), and immediate or delayed Reconstruction.
  • Radiation Therapy: Used post-operatively for local control.
  • Chemotherapy: Cytotoxic drug therapy where the primary nursing priority is infection prevention due to severe bone marrow suppression and neutropenia.
  • Hormonal Therapy & Adverse Effects:
  • Tamoxifen: Selective estrogen receptor modulator that increases the risk of developing endometrial cancer and Deep Vein Thrombosis (DVT).
  • Aromatase Inhibitors: Estrogen-depriving agents that increase the risk of osteoporosis and bone fractures.

• Health Promotion and Preventive Risk Reduction:

  • Early Detection Effect: Early identification significantly decreases overall mortality.
  • Breast Self-Awareness: Patients should know what is normal for their bodies; routine structured Breast Self-Examination (BSE) is optional.
  • Symptoms to Report Immediately: New breast lumps, skin changes (dimpling, redness, thickening), nipple retraction, or spontaneous discharge.
  • Modifiable Risk Factors: Maintain a healthy body weight, participate in regular exercise, limit alcohol intake, avoid smoking, and practice breastfeeding for at least $1\text{ year}$ ($\ge 1\text{ year}$).
  • Nutrition: Increase consumption of fruits, vegetables, and whole grains while decreasing red and processed meats.

Cancers of the Female Reproductive Tract

• Nursing Process in Reproductive Oncology:

  • Health History Assessment: Evaluate risk factors including early menarche, late menopause, history of STIs, exogenous hormone use, infertility history, personal or family history of cancer, and lifestyle factors.
  • Symptom Review: Evaluate complaints of abnormal vaginal bleeding, postcoital bleeding, or unexplained pelvic discomfort.
  • Physical Examination: Perform a full Review of Systems (ROS), complete breast examination, and pelvic assessment for masses or visible mucosal lesions.
  • Patient Teaching & Psychosocial Support: Educate on modifiable risk factors (obesity, smoking, alcohol use) and expected diagnostic procedures; provide empathetic support and validate emotional distress (Teaching Guidelines 8.1).
  • Cultural Sensitivity: Maintain awareness that discussing cancer or sharing a terminal diagnosis is viewed as taboo or impolite in certain cultures.

• Ovarian Cancer:

  • Clinical Overview: Known as the "Overlooked Disease & Silent Killer" because early symptoms are vague and non-specific (bloating, early satiety, pelvic pressure), leading to late-stage diagnosis after metastasis has occurred.
  • Genetic Risk Factors: $BRCA1$ and $BRCA2$ gene mutations increase breast cancer risk up to $80\%$ and ovarian cancer risk up to $40\%$. Genetic counseling is recommended for patients with strong family histories.
  • Diagnostic Marker: $CA-125$ serum tumor marker is elevated in ovarian cancer as well as other gynecologic malignancies.
  • Management Protocol:
  • Surgery: Total Abdominal Hysterectomy (TAH — removal of uterus and cervix) plus Bilateral Salpingo-Oophorectomy (BSO — removal of both fallopian tubes and ovaries), peritoneal/omental exploration, and tissue biopsies.
  • Adjuvant Therapy: Staging-directed chemotherapy and radiation therapy.
  • Long-Term Management: Ongoing clinical follow-up is essential.

• Endometrial Cancer:

  • Clinical Overview: The most common gynecologic malignancy in the United States, typically caught early.
  • Risk Factors: Risk increases with obesity, unopposed estrogen therapy, nulliparity, infertility, and metabolic syndrome.
  • Hallmark Warning Sign: Postmenopausal bleeding is a primary red flag requiring immediate investigation.
  • Diagnostic Pathway: Transvaginal Ultrasound (TVUS) showing endometrial thickness $\le 4\,\text{mm}$ indicates low risk; thickness greater than $4\,\text{mm}$ requires an endometrial biopsy.
  • Management: Surgical resection via TAH + BSO; radiation or chemotherapy for advanced stages. High risk of recurrence exists within the first $3\text{ years}$ post-treatment (Teaching Guidelines 8.2).

• Cervical Cancer:
  • Etiology & Transmission: Caused primarily by persistent infection with Human Papillomavirus (HPV types 16 & 18). Transmitted via vaginal, anal, oral sex, and skin-to-skin intimate contact.
  • Risk Factors: Early age at first sexual activity, multiple sexual partners, cigarette smoking, immunosuppression, and history of co-existing STIs.
  • Key Symptom: Abnormal vaginal bleeding, particularly postcoital bleeding.
  • Screening & Prevention: Pap smear with or without HPV co-testing starting at age $21$. Primary prevention includes the HPV vaccine (Gardasil 9) combined with routine screening.
  • Prognosis: Highly preventable and treatable when detected early (Box 8.1).

• Vaginal Cancer:
  • Clinical Overview: Rare malignancy ($1\%$ to $2\%$ of gynecologic cancers) that is most commonly metastatic from neighboring sites.
  • Risk Factors & Demographics: Strongly linked to HPV infection ($\sim 75\%$ of cases); incidence increases with age $>70$. Most common histology is squamous cell carcinoma.
  • Symptoms: Painless vaginal bleeding, postcoital bleeding, and dyspareunia.
  • Diagnosis & Treatment: Pelvic exam paired with colposcopy/biopsy. Treatment includes radiation therapy with or without stage-dependent surgery.

• Vulvar Cancer:
  • Clinical Overview: Rare but aggressive malignancy that presents as a visible lesion, allowing for early detection upon examination.
  • Risk Factors: Postmenopausal age, chronic HPV (type 16) infection, smoking, and Lichen Sclerosus.
  • Symptoms: Persistent vulvar pruritus, palpable lump or mass, bleeding, and localized pain.
  • Diagnosis & Treatment: Tissue biopsy of any suspicious vulvar lesion. Managed via surgical resection with or without adjuvant radiation/chemotherapy.
  • Patient Education: Perform monthly vulvar self-examinations, report persistent itching or lumps immediately, and pursue HPV prevention.